{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:32:20Z","timestamp":1786483940920,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670610"],"award-info":[{"award-number":["81670610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515013163"],"award-info":[{"award-number":["2024A1515013163"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010112","name":"Nanfang Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["2024CR006"],"award-info":[{"award-number":["2024CR006"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["2023A019"],"award-info":[{"award-number":["2023A019"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xkme.2026.101426","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:14:19Z","timestamp":1780557259000},"page":"101426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal-Limited Thrombotic Microangiopathy in Infants: A Case Series"],"prefix":"10.1016","volume":"8","author":[{"given":"Haiyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1962-8626","authenticated-orcid":false,"given":"Liangzhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xkme.2026.101426_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","article-title":"Renal thrombotic microangiopathy: a review","volume":"81","author":"Genest","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2026.101426_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.kint.2024.05.021","article-title":"An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group","volume":"106","author":"Nester","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2026.101426_bib3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases","volume":"98","author":"Veyradier","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.xkme.2026.101426_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-14-3","article-title":"Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome","volume":"14","author":"Sall\u00e9e","year":"2013","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101426_bib5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.kint.2024.02.014","article-title":"Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies","volume":"105","author":"Maisons","year":"2024","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2026.101426_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2026.101426_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100690","article-title":"Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy","volume":"38","author":"van Doorn","year":"2025","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101426_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.akdh.2023.09.003","article-title":"Thrombotic microangiopathies and the kidney","volume":"31","author":"Java","year":"2024","journal-title":"Adv Kidney Dis Health"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2026.101426_bib9","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1182\/blood-2018-99-117723","article-title":"Clinical associations, treatment, and outcomes of renal-limited thrombotic microangiopathy","volume":"132","author":"Saba","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.xkme.2026.101426_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0272-6386(12)81010-9","article-title":"Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy","volume":"23","author":"Hochstetler","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2026.101426_bib11","first-page":"401","article-title":"Expert consensus on the diagnosis and treatment of atypical hemolytic uremic syndrome in Chinese children (2023 version)","volume":"38","year":"2023","journal-title":"Chin J Appl Clin Pediatr"},{"issue":"21","key":"10.1016\/j.xkme.2026.101426_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111414","article-title":"Molecular basis, diagnostic challenges and therapeutic approaches of Bartter and Gitelman syndromes: a primer for clinicians","volume":"22","author":"Nu\u00f1ez-Gonzalez","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.xkme.2026.101426_bib13","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.3390\/biomedicines11102762","article-title":"A current landscape on Alport syndrome cases: characterization, therapy and management perspectives","volume":"11","author":"Mahrous","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.xkme.2026.101426_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0034-1375296","article-title":"Genetics of atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.xkme.2026.101426_bib15","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1159\/000502289","article-title":"Life-threatening extrarenal manifestations in an infant with atypical hemolytic uremic syndrome caused by a complement 3-gene mutation","volume":"44","author":"Han","year":"2019","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"10.1016\/j.xkme.2026.101426_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.kint.2018.02.029","article-title":"Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2026.101426_bib17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.kint.2017.04.028","article-title":"Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland","volume":"92","author":"Brocklebank","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101426_bib18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fimmu.2019.01282","article-title":"Clinical and immunological profile of anti-factor H antibody associated atypical hemolytic uremic syndrome: a nationwide database","volume":"10","author":"Puraswani","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101426_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000513009","article-title":"Clinical and genetic characteristics of atypical hemolytic uremic syndrome in children: a Chinese cohort study","volume":"145","author":"Wu","year":"2021","journal-title":"Nephron"},{"issue":"13","key":"10.1016\/j.xkme.2026.101426_bib20","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.xkme.2026.101426_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ckj\/sfx078","article-title":"Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome","volume":"11","author":"Khandelwal","year":"2018","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.xkme.2026.101426_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000497779","article-title":"Mother and child reunion in \u201chypertensive\u201d end-stage renal disease: will they complement each other?","volume":"142","author":"Timmermans","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.xkme.2026.101426_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21037\/aob-22-40","article-title":"Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46","volume":"8","author":"Wu","year":"2023","journal-title":"Ann Blood"},{"issue":"1","key":"10.1016\/j.xkme.2026.101426_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-015-0029-z","article-title":"Complement regulator CD46: genetic variants and disease associations","volume":"9","author":"Liszewski","year":"2015","journal-title":"Hum Genomics"},{"issue":"17","key":"10.1016\/j.xkme.2026.101426_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713041","article-title":"The rationale of complement blockade of the MCPggaac haplotype following atypical hemolytic uremic syndrome of three southeastern European countries with a literature review","volume":"24","author":"Turudic","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.xkme.2026.101426_bib26","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101426_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.xkme.2026.101426_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of factor I-associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2026.101426_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jcla.20154","article-title":"Hypercomplementemia in adult patients with IgA nephropathy","volume":"21","author":"Onda","year":"2007","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"10.1016\/j.xkme.2026.101426_bib30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3899\/jrheum.2024-0437","article-title":"Understanding the Role of the complement system in insulin resistance and metabolic syndrome in patients with rheumatoid arthritis","volume":"51","author":"Rodr\u00edguez-Gonz\u00e1lez","year":"2024","journal-title":"J Rheumatol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:07:33Z","timestamp":1786482453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2590059526001883"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101426","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal-Limited Thrombotic Microangiopathy in Infants: A Case Series","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101426"}}